SURMOUNT-4 will address the question of weight regain after stopping the drug: patients who took tirzepatide for 6 months, will be assessed for sustained weight loss one year later (NCT04660643)
10.1146/annurev.pharmtox.45.120403.100004
Khng s dng sn phm cho nhng ngi mn cm vi thnh phn vin ung, ph n c thai, cho con b, tr em, ngi c bnh ang cha tr
Movement Disorder Society-Unified Parkinsons Disease Rating Scale Part III (MDS-UPDRS-III), Pearsons r = 0.162, P = 0.037), cognition (Mini-Mental State Examination (MMSE), r = 0.161, P = 0.038), anxiety (Hamilton Anxiety Rating Scale (HAMA), r = 0.186, P = 0.017) and depression (Hamilton Depression Rating Scale (HAMD), r = 0.177, P = 0.023)
10.1039/d1fo01360b 17 DoT
Nerve and Neurological Support For nerve injury, neuropathy, or post-concussion recovery, BPC-157 may assist with neural regeneration and inflammation reduction